Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial G Ronco, P Giorgi-Rossi, F Carozzi, M Confortini, P Dalla Palma, ... The lancet oncology 11 (3), 249-257, 2010 | 1195 | 2010 |
Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial G Ronco, N Segnan, P Giorgi-Rossi, M Zappa, GP Casadei, F Carozzi, ... Journal of the National Cancer Institute 98 (11), 765-774, 2006 | 426 | 2006 |
Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test G Ronco, P Giorgi-Rossi, F Carozzi, M Confortini, PD Palma, A Del Mistro, ... Journal of the National Cancer Institute 100 (7), 492-501, 2008 | 380 | 2008 |
Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT AL Pegna, G Picozzi, M Mascalchi, FM Carozzi, L Carrozzi, C Comin, ... Lung cancer 64 (1), 34-40, 2009 | 359 | 2009 |
Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial E Paci, D Puliti, AL Pegna, L Carrozzi, G Picozzi, F Falaschi, F Pistelli, ... Thorax 72 (9), 825-831, 2017 | 311 | 2017 |
Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial G Ronco, P Giorgi-Rossi, F Carozzi, P Dalla Palma, A Del Mistro, ... The Lancet Oncology 7 (7), 547-555, 2006 | 302 | 2006 |
Categorizing breast mammographic density: intra-and interobserver reproducibility of BI-RADS density categories S Ciatto, N Houssami, A Apruzzese, E Bassetti, B Brancato, F Carozzi, ... The Breast 14 (4), 269-275, 2005 | 286 | 2005 |
Characterization of cervico-vaginal microbiota in women developing persistent high-risk Human Papillomavirus infection M Di Paola, C Sani, AM Clemente, A Iossa, E Perissi, G Castronovo, ... Scientific reports 7 (1), 10200, 2017 | 276 | 2017 |
Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial F Carozzi, M Confortini, P Dalla Palma, A Del Mistro, A Gillio-Tos, ... The lancet oncology 9 (10), 937-945, 2008 | 257 | 2008 |
Eurogin roadmap 2017: triage strategies for the management of HPV‐positive women in cervical screening programs K Cuschieri, G Ronco, A Lorincz, L Smith, G Ogilvie, L Mirabello, ... International journal of cancer 143 (4), 735-745, 2018 | 191 | 2018 |
Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested … F Carozzi, A Gillio-Tos, M Confortini, A Del Mistro, C Sani, L De Marco, ... The lancet oncology 14 (2), 168-176, 2013 | 185 | 2013 |
The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600) P Giorgi Rossi, LM Marsili, L Camilloni, A Iossa, A Lattanzi, C Sani, ... British journal of cancer 104 (2), 248-254, 2011 | 160 | 2011 |
Four-year results of low-dose CT screening and nodule management in the ITALUNG trial AL Pegna, G Picozzi, F Falaschi, L Carrozzi, M Falchini, FM Carozzi, ... Journal of Thoracic Oncology 8 (7), 866-875, 2013 | 156 | 2013 |
Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples MT Sandri, P Lentati, E Benini, P Dell'Orto, L Zorzino, FM Carozzi, ... Journal of clinical microbiology 44 (6), 2141-2146, 2006 | 149 | 2006 |
Reproducibility of HPV DNA testing by Hybrid Capture 2 in a screening setting: intralaboratory and interlaboratory quality control in seven laboratories participating in the … FM Carozzi, AD Mistro, M Confortini, C Sani, D Puliti, R Trevisan, ... American journal of clinical pathology 124 (5), 716-721, 2005 | 119 | 2005 |
HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology G Ronco, J Cuzick, N Segnan, S Brezzi, F Carozzi, S Folicaldi, ... European Journal of Cancer 43 (3), 476-480, 2007 | 113 | 2007 |
Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients M Mangoni, S Bisanzi, F Carozzi, C Sani, G Biti, L Livi, E Barletta, ... International Journal Of Radiation Oncology* Biology* Physics 81 (1), 52-58, 2011 | 107 | 2011 |
Reduced and full-preparation CT colonography, fecal immunochemical test, and colonoscopy for population screening of colorectal cancer: a randomized trial L Sali, M Mascalchi, M Falchini, L Ventura, F Carozzi, G Castiglione, ... Journal of the National Cancer Institute 108 (2), djv319, 2016 | 103 | 2016 |
Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors G Ronco, A Biggeri, M Confortini, C Naldoni, N Segnan, M Sideri, ... Epidemiologia e prevenzione 36 (3-4 Suppl 1), e1-72, 2012 | 101* | 2012 |
Prevalence of human papillomavirus types in high-grade cervical intraepithelial neoplasia and cancer in Italy FM Carozzi, ML Tornesello, E Burroni, G Loquercio, G Carillo, C Angeloni, ... Cancer epidemiology, biomarkers & prevention 19 (9), 2389-2400, 2010 | 83 | 2010 |